BEAM: A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Melanoma

PURPOSE: Metastatic melanoma, a highly vascularized tumor with strong expression of vascular endothelial growth factor, has an overall poor prognosis. We conducted a placebo-controlled, double-blind phase II study of carboplatin plus paclitaxel with or without bevacizumab in patients with previously...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Clin Oncol
Prif Awduron: Kim, Kevin B., Sosman, Jeffrey A., Fruehauf, John P., Linette, Gerald P., Markovic, Svetomir N., McDermott, David F., Weber, Jeffrey S., Nguyen, Hoa, Cheverton, Peter, Chen, Daniel, Peterson, Amy C., Carson, William E., O'Day, Steven J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Clinical Oncology 2012
Pynciau:
Original Reports
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4669379/
https://ncbi.nlm.nih.gov/pubmed/22124101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.34.6270
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg